Javier Rodriguez is Officer of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 9,133 shares of BTAI, which is worth approximately $5,845. The most recent transaction as insider was on Sep 16, 2024, when has been sold 345 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $238. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.13K
8.8% 3M change
69.38% 12M change
Total Value Held $5,845

Javier Rodriguez Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2024
SELL
Open market or private sale
$238 $0.69 p/Share
345 Reduced 3.64%
9,133 Common Stock
Sep 15 2024
BUY
Exercise of conversion of derivative security
-
563 Added 5.61%
9,478 Common Stock
Sep 14 2024
BUY
Exercise of conversion of derivative security
-
521 Added 5.52%
8,915 Common Stock
Jun 17 2024
SELL
Open market or private sale
$454 $1.26 p/Share
361 Reduced 4.12%
8,394 Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
562 Added 6.03%
8,755 Common Stock
Jun 14 2024
BUY
Exercise of conversion of derivative security
-
521 Added 5.98%
8,193 Common Stock
Apr 04 2024
SELL
Open market or private sale
$2,671 $2.64 p/Share
1,012 Reduced 11.65%
7,672 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
2,250 Added 20.58%
8,684 Common Stock
Mar 14 2024
BUY
Exercise of conversion of derivative security
-
521 Added 7.49%
6,434 Common Stock
Dec 14 2023
BUY
Exercise of conversion of derivative security
-
521 Added 8.1%
5,913 Common Stock
Sep 14 2023
BUY
Exercise of conversion of derivative security
-
521 Added 8.81%
5,392 Common Stock
Jun 14 2023
BUY
Exercise of conversion of derivative security
-
521 Added 9.66%
4,871 Common Stock
May 15 2023
SELL
Open market or private sale
$48,766 $27.32 p/Share
1,785 Reduced 29.1%
4,350 Common Stock
May 14 2023
BUY
Exercise of conversion of derivative security
-
5,000 Added 44.9%
6,135 Common Stock
Mar 15 2023
SELL
Open market or private sale
$18,639 $19.62 p/Share
950 Reduced 45.56%
1,135 Common Stock
Mar 14 2023
BUY
Exercise of conversion of derivative security
-
2,084 Added 50.0%
2,084 Common Stock
JR

Javier Rodriguez

Officer
New Haven, CT

Track Institutional and Insider Activities on BTAI

Follow BioXcel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

News

Receive news related to BioXcel Therapeutics, Inc.

Track Activities on BTAI